10.1089/acm.2013.0036 J
Triiodothyronine promotes the phenotypic maturation of DCs by regulating main histocompatibility complex-II (MHC-II) and costimulatory molecules
Abstract Purpose The association between melanosis coli (MC) and colorectal neoplasms remains unclear
When to Consider Dose Adjustment or Medication Change In some cases, the severity of hair loss or other side effects may warrant reconsidering your GLP-1 treatment approach: Considerations for Adjustment: Extremely rapid weight loss (more than 3 pounds weekly sustained) Severe hair shedding thats psychologically distressing Inability to maintain adequate nutrition despite best efforts Multiple concerning side effects beyond hair loss Options to Discuss with Your Provider: Reducing GLP-1 dose to slow weight loss Switching to a different GLP-1 medication Taking a medication holiday to allow stabilization, then resuming Exploring alternative weight loss approaches Critical Point: Dr
Enjalbert B, Smith DA, Cornell MJ, Alam I, Nicholls S, et al
Mechanism of Action: Why It Makes Sense for Athletes Sermorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile GH release and downstream insulin-like growth factor-1 (IGF-1) production. Growth hormone and IGF-1 influence several systems relevant to performance: Protein synthesis and muscle repair Collagen formation and tendon remodeling Lipolysis and metabolic efficiency Sleep architecture, particularly slow-wave sleep Because GH secretion is naturally highest during deep sleep, sermorelin is typically administered at night to align with this physiology
